- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03264092
Comparison of Three Tissue Acquiring Techniques During EUS Guided Biopsies of Solid Tumors.
Comparison of Three Different Tissue Acquisition Techniques During Endoscopic Ultrasound-guide Fine Needle Biopsies of Solid Tumors: A Randomized Single Blind Clinical Trial.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Endoscopic ultrasound guided fine-needle aspiration (EUS-FNA) has been used since 1990's for the diagnosis and staging of esophageal, gastric, duodenal, pancreatobiliary, rectal mediastinal lesions and intra-abdominal lymphadenopathy. Studies have shown a variable range of specimen adequacy when performing pancreatic biopsies with the standard fine needle aspiration (FNA) needles with this modality. There are several factors that affect the overall diagnostic yield of this procedure, such as endosonographer experience, presence of cytopathologist during the procedure, the needle diameter and the number of passes. In this study we will compare the yield of recently available fine biopsy needles (FNB) using three different techniques to obtain samples from solid lesions. The three techniques to be compared in this study are: stylet slow pull (SP) vs dry suction (DS) vs wet suction (WS).
wall cells.
In the "suction technique" the stylet of the needle can be left in place or removed before puncturing the lesion. Once the needle is inside the target, negative pressure is applied through a 10 or 20 cc syringe connected to the needle.
The wet suction technique consists of flushing of the needle with 5 ml of saline solution to replace the column of air within the lumen of needle with saline solution before needle aspiration. Once the needle is flushed, negative pressure is applied with a 10 or 20 cc syringe connected to the needle.
In the slow pull technique, the stylet is left in place in the needle and is slightly retracted prior to puncturing the lesion. Once the needle is inside the target, the stylet is pushed completely into the needle to remove any contaminant cells and several back and forth movements are done while slowly withdrawing the stylet.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Texas
-
El Paso, Texas, United States, 79905
- Texas Tech University Health Sciences Center El Paso
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Ages between 18-80 years old
- Sex: male or female
- Patients who require EUS and tissue sampling of solid solid lesions (size >1 cm) anywhere in the following locations: lymph nodes, stomach, esophagus, colon, small intestine, pancreas, liver, spleen or kidney.
- Patients who are able to give consent
Exclusion Criteria:
- Pregnant female
- Coagulation disorders (platelets < 50,000/mm3, INR > 2)
- Patients with acute pancreatitis in the immediate 2 weeks prior to the procedure.
- Cardiorespiratory dysfunction that precludes sedation.
- Unable to provide informed consent
Study Plan
How is the study designed?
Design Details
- Primary Purpose: DIAGNOSTIC
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: SINGLE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
EXPERIMENTAL: Wet suction
This arm will include all the patients that will get an endoscopic ultrasound guided fine needle biopsy done with the wet suction technique
|
Using the echoendoscope the lesion is identified and the needle is inserted in it to obtain a biopsy also under sonographic guidance
|
|
EXPERIMENTAL: Dry suction
This arm will include all the patients that will get and endoscopic ultrasound guided fine needle biopsy done with the dry suction technique
|
Using the echoendoscope the lesion is identified and the needle is inserted in it to obtain a biopsy also under sonographic guidance
|
|
EXPERIMENTAL: Slow pull
This arm will include all the patients that will get an endoscopic ultrasound guided fine needle biopsy done with the slow pull technique
|
Using the echoendoscope the lesion is identified and the needle is inserted in it to obtain a biopsy also under sonographic guidance
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Cellularity of Specimens Obtained by Each Individual Technique Based on Cellularity Score
Time Frame: 2 hours
|
0: inadequate
|
2 hours
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Blood Contamination Score of Each Specimen Obtained
Time Frame: 2 hours
|
This is based on the following scale
|
2 hours
|
|
Number of Participants Stratified Per the Number of Diagnostic Passes Required
Time Frame: 2 hours
|
This indicates which out of the 3 passes provided enough tissue for diagnosis.
If after 3 passes not enough tissue was obtained, the doctor was free to use the technique of his preference outside of the protocol.
|
2 hours
|
Collaborators and Investigators
Investigators
- Principal Investigator: Antonio Mendoza Ladd, MD, Texas Tech University Health Sciences Center, El Paso
Publications and helpful links
General Publications
- Yamao K, Sawaki A, Mizuno N, Shimizu Y, Yatabe Y, Koshikawa T. Endoscopic ultrasound-guided fine-needle aspiration biopsy (EUS-FNAB): past, present, and future. J Gastroenterol. 2005 Nov;40(11):1013-23. doi: 10.1007/s00535-005-1717-6.
- Puri R, Vilmann P, Saftoiu A, Skov BG, Linnemann D, Hassan H, Garcia ES, Gorunescu F. Randomized controlled trial of endoscopic ultrasound-guided fine-needle sampling with or without suction for better cytological diagnosis. Scand J Gastroenterol. 2009;44(4):499-504. doi: 10.1080/00365520802647392.
- Mendoza Ladd A, Casner N, Cherukuri SV, Garcia C, Padilla O, Dwivedi A, Hakim N. Fine Needle Biopsies of Solid Pancreatic Lesions: Tissue Acquisition Technique and Needle Design Do Not Impact Specimen Adequacy. Dig Dis Sci. 2022 Sep;67(9):4549-4556. doi: 10.1007/s10620-021-07316-4. Epub 2021 Dec 2.
Study record dates
Study Major Dates
Study Start (ACTUAL)
Primary Completion (ACTUAL)
Study Completion (ACTUAL)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (ACTUAL)
Study Record Updates
Last Update Posted (ACTUAL)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- E17118
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Solid Tumor
-
Avelos Therapeutics Inc.RecruitingSolid Tumor | Solid Tumor Cancer | Solid Tumor, Adult | Solid Tumor, Unspecified, Adult | Tumor, Solid | Solid Tumor in Advanced Stage | Solid Tumors Refractory to Standard TherapyKorea, Republic of
-
Monopar TherapeuticsAvailableCancer | Solid Tumor | Solid Tumor Cancer | Oncology | uPAR-positive Solid Tumor | Urokinase Plasminogen Activator Receptor-positive Solid TumorUnited States
-
Sorrento Therapeutics, Inc.WithdrawnSolid Tumor | Relapsed Solid Tumor | Refractory Tumor
-
Memorial Sloan Kettering Cancer CenterRecruitingSolid Tumor | Solid Tumor, Adult | Solid Tumor, Unspecified, AdultUnited States
-
Memorial Sloan Kettering Cancer CenterLincoln Medical and Mental Health CenterRecruitingSolid Tumor | Solid Tumor, Adult | Solid Tumor, Unspecified, AdultUnited States, Puerto Rico
-
Memorial Sloan Kettering Cancer CenterLincoln Medical and Mental Health CenterRecruitingSolid Tumor | Solid Tumor, Adult | Solid Tumor, Unspecified, AdultUnited States, Puerto Rico
-
Impact Therapeutics, Inc.RecruitingSolid Tumor | Advanced Solid TumorChina, Australia, Taiwan, United States
-
Partner Therapeutics, Inc.WithdrawnSolid Tumor | Solid Tumor, AdultUnited States
-
RemeGen Co., Ltd.CompletedMetastatic Solid Tumor | Locally Advanced Solid Tumor | Unresectable Solid TumorAustralia
-
Aadi Bioscience, Inc.RecruitingAdvanced Solid Tumor | Tumor | Tumor, SolidUnited States
Clinical Trials on Endoscopic ultrasound guided fine needle biopsy
-
University of BolognaCompletedPancreatic Adenocarcinoma | Pancreas Cancer | Pancreas MetastasesItaly
-
National Taiwan University HospitalCompleted
-
Azienda Ospedaliera Universitaria Integrata VeronaCompletedEndoscopic Ultrasound | Solid Pancreatic NeoplasmsItaly
-
Asian Institute of Gastroenterology, IndiaNot yet recruitingCholangiocarcinoma PatientsIndia
-
Assiut UniversityUnknown
-
Institutul Regional de Gastroenterologie & Hepatologie...Recruiting
-
National Taiwan University HospitalRecruiting
-
Azienda Ospedaliera Universitaria Integrata VeronaActive, not recruitingEndoscopic Ultrasound | Fine-needle AspirationItaly
-
Chungnam National UniversityCompleted
-
University of Sao Paulo General HospitalBoston Scientific Corporation; Medi - GlobeCompletedPancreatic NeoplasmBrazil